
Loading, please wait...

Loading, please wait...

Mesenchymal stem cells (MSCs) have gained significant traction in the treatment of various musculoskeletal disorders. Therefore, understanding mesenchymal stem cell therapy is essential for modern orthopaedic practice. These cells possess unique properties like self-renewal and multilineage differentiation. However, clinical application must always remain evidence-based and aligned with local laws.
Clinical outcomes in orthopaedics depend heavily on disease pathophysiology. Specifically, practitioners use MSCs to treat osteoarthritis, cartilage defects, and nonunion fractures. Recent research indicates that MSCs modulate the local environment through paracrine signaling. This biological activity promotes tissue repair and reduces inflammation in damaged joints.
In India, the Indian Council of Medical Research (ICMR) updated the National Guidelines for Stem Cell Research in 2025. These rules mandate that practitioners conduct all stem cell interventions within a research or clinical trial framework. Furthermore, a 2026 Supreme Court advisory emphasized that MSCs are not currently \"Standard Care\" for most conditions. Consequently, surgeons must obtain approval from Institutional Ethics Committees before offering these treatments to patients.
Patient safety remains the top priority during clinical application. Doctors must ensure comprehensive informed consent and communicate clearly regarding the experimental nature of the therapy. Additionally, they should monitor patients for long-term adverse effects as part of rigorous clinical documentation to ensure regulatory compliance and ethical practice.
No, the 2026 advisory clarifies that it is not yet standard care. Surgeons must only utilize it within approved research protocols and registered clinical trials.
Surgeons typically use bone marrow aspirate concentrate (BMAC), adipose-derived tissues, and umbilical cord-derived cells for these procedures.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional recommendation. Refer to the latest local and national guidelines for clinical practice.
References
1. Dilogo IH et al. Clinical application of mesenchymal stem cells in orthopaedics and traumatology in daily practice. EFORT Open Rev. 2026 May 01. doi: 10.1530/EOR-2026-0056. PMID: 42065225.
2. Indian Council of Medical Research (ICMR). National Guidelines for Stem Cell Research 2025.
3. Ministry of Health and Family Welfare (MoHFW) / Supreme Court of India Advisory. Regulatory Framework for Stem Cell Interventions. 2026.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A review of MSC applications in orthopaedics and a guide to India's 2025-2026 regulatory landscape for clinical practice....
2 months ago

Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today

An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back

A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back

Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back

With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today